The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens

Bibliography

• Nicholls EF, Madera L, Hancock RE. Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Ann NY Acad Sci 2010;1213:46-61
   PubMed Web of Science ®Google Scholar
• Freeman BE, Hammarlund E, Raué HP, Slifka MK. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci USA 2012;109(25):9971-6
   PubMed Web of Science ®Google Scholar
• Kim JJ, Yang JS, Dentchev T, et al. Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J Interferon Cytokine Res 2000;20(5):487-98
   PubMed Web of Science ®Google Scholar
• Bode C, Zhao G, Steinhagen F, et al. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2011;10(4):499-511
   PubMed Web of Science ®Google Scholar
• Hong F, Hansen RD, Yan J, et al. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res 2003;63(24):9023-31
   PubMed Web of Science ®Google Scholar
• Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004;16(2):157-62
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002;2(11):850-61
   PubMed Web of Science ®Google Scholar
• Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3(9):710-20
   PubMed Web of Science ®Google Scholar
• Hoover DM, Rajashankar KR, Blumenthal R, et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 2000;275(42):32911-18
   PubMed Web of Science ®Google Scholar
• Vora P, Youdim A, Thomas LS, et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004;173(9):5398-405
   PubMed Web of Science ®Google Scholar
• Hertz CJ, Wu Q, Porter EM, et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 2003;171(12):6820-6
   PubMed Web of Science ®Google Scholar
• Biragyn A, Ruffini PA, Leifer CA, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002;298(5595):1025-9
   PubMed Web of Science ®Google Scholar
• Perregaux DG, Bhavsar K, Contillo L, et al. Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity. J Immunol 2002;168(6):3024-32
   PubMed Web of Science ®Google Scholar
• Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004;111(3):273-81
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 2003;62(Suppl 2):ii17-21
   PubMedGoogle Scholar
• Kane CD, Schuch R, Day WA Jr, Maurelli AT. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system. J Bacteriol 2002;184(16):4409-19
   PubMed Web of Science ®Google Scholar
• Peschel A, Otto M, Jack RW, et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999;274(13):8405-10
   PubMed Web of Science ®Google Scholar
• Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76(2):287-99
   PubMed Web of Science ®Google Scholar
• Burgdorf S, Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 2008;20(1):89-95
   PubMed Web of Science ®Google Scholar
• Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999;5(4):285-94
   PubMed Web of Science ®Google Scholar
• Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254(5032):707-10
   PubMed Web of Science ®Google Scholar
• Snapper CM, Peçanha LM, Levine AD, Mond JJ. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol 1991;147(4):1163-70
   PubMed Web of Science ®Google Scholar
• Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8(3):223-46
   PubMedGoogle Scholar
• Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000;1(3):199-205
   PubMed Web of Science ®Google Scholar
• Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994;102(6):828-32
   PubMed Web of Science ®Google Scholar
• Carvalho EM, Bacellar O, Brownell C, et al. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994;152(12):5949-56
   PubMed Web of Science ®Google Scholar
• Ghalib HW, Piuvezam MR, Skeiky YA, et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993;92(1):324-9
   PubMed Web of Science ®Google Scholar
• Pirmez C, Yamamura M, Uyemura K, et al. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993;91(4):1390-5
   PubMed Web of Science ®Google Scholar
• Surcel HM, Troye-Blomberg M, Paulie S, et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81(2):171-6
   PubMed Web of Science ®Google Scholar
• Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000;181(1):385-9
   PubMed Web of Science ®Google Scholar
• Viganó A, Principi N, Villa ML, et al. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J Pediatr 1995;126(3):368-74
   PubMed Web of Science ®Google Scholar
• Viganó A, Principi N, Crupi L, et al. Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995;95(2):627-32
   PubMed Web of Science ®Google Scholar
• Crotty S, Ahmed R. Immunological memory in humans. Semin Immunol 2004;16(3):197-203
   PubMed Web of Science ®Google Scholar
• Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004;22:745-63
   PubMed Web of Science ®Google Scholar
• Hengel H, Koszinowski UH. Interference with antigen processing by viruses. Curr Opin Immunol 1997;9(4):470-6
   PubMed Web of Science ®Google Scholar
• Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999;17:739-79
   PubMed Web of Science ®Google Scholar
• Levitskaya J, Sharipo A, Leonchiks A, et al. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 1997;94(23):12616-21
   PubMed Web of Science ®Google Scholar
• York IA. Immune evasion strategies of the herpesviruses. Chem Biol 1996;3(5):331-5
   PubMed Web of Science ®Google Scholar
• York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996;14:369-96
   PubMed Web of Science ®Google Scholar
• Ahn K, Angulo A, Ghazal P, et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 1996;93(20):10990-5
   PubMed Web of Science ®Google Scholar
• Aiken C, Konner J, Landau NR, et al. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994;76(5):853-64
   PubMed Web of Science ®Google Scholar
• Schwartz O, Maréchal V, Le Gall S, et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996;2(3):338-42
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Bronson S, Lock M, et al. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J 1997;16(23):6964-76
   PubMed Web of Science ®Google Scholar
• Collins KL, Chen BK, Kalams SA, et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391(6665):397-401
   PubMed Web of Science ®Google Scholar
• Hoglund P, Sundbäck J, Olsson-Alheim MY, et al. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997;155:11-28
   PubMed Web of Science ®Google Scholar
• Karre K. How to recognize a foreign submarine. Immunol Rev 1997;155:5-9
   Google Scholar
• Miller DM, Rahill BM, Boss JM, et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998;187(5):675-83
   PubMed Web of Science ®Google Scholar
• Sedmak DD, Guglielmo AM, Knight DA, et al. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994;144(4):683-92
   PubMed Web of Science ®Google Scholar
• Kalvakolanu DV. Virus interception of cytokine-regulated pathways. Trends Microbiol 1999;7(4):166-71
   PubMed Web of Science ®Google Scholar
• Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000;81(Pt 10):2341-64
   PubMed Web of Science ®Google Scholar
• Tortorella D, Gewurz BE, Furman MH, et al. Viral subversion of the immune system. Annu Rev Immunol 2000;18:861-926
   PubMed Web of Science ®Google Scholar
• Smith GL, Symons JA, Khanna A, et al. Vaccinia virus immune evasion. Immunol Rev 1997;159:137-54
   PubMed Web of Science ®Google Scholar
• Zdanov A, Schalk-Hihi C, Menon S, et al. Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10. J Mol Biol 1997;268(2):460-7
   PubMed Web of Science ®Google Scholar
• Strockbine LD, Cohen JI, Farrah T, et al. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 1998;72(5):4015-21
   PubMed Web of Science ®Google Scholar
• Karp CL, Scott IU, Chang TS, Pflugfelder SC. Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency virus infection? Arch Ophthalmol 1996;114(3):257-61
   PubMed Web of Science ®Google Scholar
• Spriggs MK. One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 1996;14:101-30
   PubMed Web of Science ®Google Scholar
• Molinari M, Salio M, Galli C, et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998;187(1):135-40
   PubMed Web of Science ®Google Scholar
• Mota LJ, Cornelis GR. The bacterial injection kit: type III secretion systems. Ann Med 2005;37(4):234-49
   PubMed Web of Science ®Google Scholar
• Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 2005;59:69-89
   PubMed Web of Science ®Google Scholar
• Gouin E, Gantelet H, Egile C, et al. A comparative study of the actin-based motilities of the pathogenic bacteria Listeria monocytogenes, Shigella flexneri and Rickettsia conorii. J Cell Sci 1999;112(Pt 11):1697-708
   PubMed Web of Science ®Google Scholar
• Hunt D, Wilson JE, Weih KA, et al. Francisella tularensis elicits IL-10 via a PGE(2)-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS One 2012;7(5):e37330
   Google Scholar
• Dramsi S, Cossart P. Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite. J Cell Biol 2002;156(6):943-6
   PubMed Web of Science ®Google Scholar
• Newton HJ, Ang DK, van Driel IR, Hartland EL. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev 2010;23(2):274-98
   PubMed Web of Science ®Google Scholar
• Gercken J, Pryjma J, Ernst M, Flad HD. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect Immun 1994;62(8):3472-8
   PubMed Web of Science ®Google Scholar
• Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 1995;181(1):257-70
   PubMed Web of Science ®Google Scholar
• Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994;263(5147):678-81
   PubMed Web of Science ®Google Scholar
• Chan LL, Cheung BK, Li JC, Lau AS. A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-gamma-induced MHC-II molecule on primary human blood macrophages. J Leukoc Biol 2010;88(2):303-11
   PubMed Web of Science ®Google Scholar
• Pai RK, Convery M, Hamilton TA, et al. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 2003;171(1):175-84
   PubMed Web of Science ®Google Scholar
• Pecora ND, Fulton SA, Reba SM, et al. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell Immunol 2009;254(2):94-104
   PubMed Web of Science ®Google Scholar
• Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 2010;8(4):296-307
   PubMed Web of Science ®Google Scholar
• Agrewala JN, Kumar B, Vohra H. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy. Clin Exp Immunol 1998;111(1):56-63
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Vaccines: past, present and future. Nat Med 2005;11(4 Suppl):S5-11
   PubMed Web of Science ®Google Scholar
• Iyer N, Marathe SA, Chaudhuri D, et al. Immunomodulation using agonists and antagonists: potential clinical applications. Expert Opin Investig Drugs 2012;21(1):67-81
   PubMed Web of Science ®Google Scholar
• Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol 2009;30(1):23-32
   PubMed Web of Science ®Google Scholar
• Morefield GL, Sokolovska A, Jiang D, et al. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 2005;23(13):1588-95
   PubMed Web of Science ®Google Scholar
• Rajput ZI, Hu SH, Xiao CW, Arijo AG. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 2007;8(3):153-61
   PubMedGoogle Scholar
• Huckriede A, Bungener L, Daemen T, Wilschut J. Influenza virosomes in vaccine development. Methods Enzymol 2003;373:74-91
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11(5):373-84
   PubMed Web of Science ®Google Scholar
• Baldridge JR, Crane RT. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. Methods 1999;19(1):103-7
   PubMed Web of Science ®Google Scholar
• Fujihashi K, Sato S, Kiyono H. Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly. Exp Gerontol 2014;54C:21-6
   Google Scholar
• Galli G, Hancock K, Hoschler K, et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci USA 2009;106(19):7962-7
   PubMed Web of Science ®Google Scholar
• Spickler AR, Roth JA. Adjuvants in veterinary vaccines: modes of action and adverse effects. J Vet Intern Med 2003;17(3):273-81
   PubMed Web of Science ®Google Scholar
• Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19(17-19):2666-72
   PubMed Web of Science ®Google Scholar
• Ott G, Barchfeld GL, Chernoff D, et al. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol 1995;6:277-96
   PubMedGoogle Scholar
• Rouleau I, De Serres G, Drolet JP, et al. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. Vaccine 2013;31(50):5989-96
   PubMed Web of Science ®Google Scholar
• Klucker MF, Dalençon F, Probeck P, Haensler J. AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method. J Pharm Sci 2012;101(12):4490-500
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Improving vaccine delivery using novel adjuvant systems. Hum Vaccin 2008;4(4):262-70
   PubMed Web of Science ®Google Scholar
• Manns MP, Pockros PJ, Norkrans G, et al. Long-term clearance of hepatitis C virus following interferon alpha-2b or peginterferon alpha-2b, alone or in combination with ribavirin. J Viral Hepat 2013;20(8):524-9
   PubMed Web of Science ®Google Scholar
• Marciano BE, Wesley R, De Carlo ES, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004;39(5):692-9
   PubMed Web of Science ®Google Scholar
• Kuritzkes DR. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 2000;30(2):256-60
   PubMed Web of Science ®Google Scholar
• Lofthouse SA, Andrews AE, Elhay MJ, et al. Cytokines as adjuvants for ruminant vaccines. Int J Parasitol 1996;26(8-9):835-42
   PubMed Web of Science ®Google Scholar
• Ahlers JD, Dunlop N, Alling DW, et al. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. J Immunol 1997;158(8):3947-58
   PubMed Web of Science ®Google Scholar
• Dockrell DH, Kinghorn GR. Imiquimod and resiquimod as novel immunomodulators. J Antimicrob Chemother 2001;48(6):751-5
   PubMed Web of Science ®Google Scholar
• Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett 2011;203(2):97-105
   PubMed Web of Science ®Google Scholar
• Herzog C, Hartmann K, Künzi V, et al. Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine. Vaccine 2009;27(33):4381-7
   PubMed Web of Science ®Google Scholar
• Bovier PA. Epaxal: a virosomal vaccine to prevent hepatitis A infection. Expert Rev Vaccines 2008;7(8):1141-50
   PubMed Web of Science ®Google Scholar
• Nussler AK, Thomson AW. Immunomodulatory agents in the laboratory and clinic. Parasitology 1992;105(Suppl):S5-23
   Google Scholar
• St Georgiev V. Immunomodulatory activity of small peptides. Trends Pharmacol Sci 1990;11(9):373-8
   PubMed Web of Science ®Google Scholar
• Briskin DP. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol 2000;124(2):507-14
   PubMed Web of Science ®Google Scholar
• Khan N, Tamboli TE, Sharma VK, Kumar S. Phytochemical and pharmacological aspects of Nothapodytes nimmoniana. Herba Pol 2013;59(1):53-66
   Google Scholar
• Xiang-guo L, Yi Zi Y, Xuan-ji J, et al. Ginsenoside content in the leaves and roots of panax ginseng at different ages. Life Sci J 2012;9(4):679-83
   Google Scholar
• Bouic PJ. Plant sterols/sterolins for optimum immunity. Positive Health. 2007
   Google Scholar
• Fraile L, Crisci E, Córdoba L, et al. Immunomodulatory properties of beta-sitosterol in pig immune responses. Int Immunopharmacol 2012;13(3):316-21
   PubMed Web of Science ®Google Scholar
• Kuduk-Jaworska J, Szpunar J, Gasiorowski K, Brokos B. Immunomodulating polysaccharide fractions of Menyanthes trifoliata L. Z Naturforsch C 2004;59(7-8):485-93
   PubMed Web of Science ®Google Scholar
• Tan BK, Vanitha J. Immunomodulatory and antimicrobial effects of some traditional chinese medicinal herbs: a review. Curr Med Chem 2004;11(11):1423-30
   PubMed Web of Science ®Google Scholar
• Zhao W, Ye Q, Tan X, et al. Three new sesquiterpene glycosides from Dendrobium nobile with immunomodulatory activity. J Nat Prod 2001;64(9):1196-200
   PubMed Web of Science ®Google Scholar
• Achan J, Talisuna AO, Erhart A, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J 2011;10:144
   PubMed Web of Science ®Google Scholar
• Sunila ES, Kuttan G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol 2004;90(2-3):339-46
   PubMed Web of Science ®Google Scholar
• Ho LJ, Juan TY, Chao P, et al. Plant alkaloid tetrandrine downregulates IκBalpha kinases IκBalpha-NFκB signaling pathway in human peripheral blood T cell. Br J Pharmacol 2004;143:919-27
   PubMed Web of Science ®Google Scholar
• Huang Y, Fang Y, Wu J, et al. Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells. Mol Cancer Ther 2004;3(3):271-7
   PubMed Web of Science ®Google Scholar
• Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999;12(4):564-82
   PubMed Web of Science ®Google Scholar
• Mencherini T, Cau A, Bianco G, et al. An extract of Apium graveolens var. dulce leaves: structure of the major constituent, apiin, and its anti-inflammatory properties. J Pharm Pharmacol 2007;59(6):891-7
   PubMed Web of Science ®Google Scholar
• Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52(4):673-751
   PubMed Web of Science ®Google Scholar
• Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005;115(3):375-87
   PubMed Web of Science ®Google Scholar
• Mishra K, Dash AP, Dey N. Andrographolide: a novel antimalarial diterpene lactone compound from andrographis paniculata and its interaction with curcumin and artesunat. J Trop Med 2011;2011:579518
   PubMedGoogle Scholar
• Patel K. A review on herbal immunoadjuvant. Int J Pharm Life Sci 2012;3(3):1568-76
   Google Scholar
• Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res 2010;1(2):112-21
   PubMedGoogle Scholar
• More P, Pai K. Immunomodulatory effects of Tinospora cordifolia (Guduchi) on macrophage activation. Biol Med 2011;3(2):134-40
   Google Scholar
• Jafarian A, Zolfaghari B, Parnianifard M. The effects of methanolic, chloroform, and ethylacetate extracts of the Cucurbita pepo L. on the delay type hypersensitivity and antibody production. Res Pharm Sci 2012;7(4):217-24
   Google Scholar
• Chawla A, Chawla P, Mangalesh Roy RC. Asparagus racemosus (Willd): biological activities & its active principles. Indo-Global J Pharm Sci 2011;1(2):113-20
   Google Scholar
• Razdan R, Roy SM. Study of the immunomodulatory activity of a polyherbal drug. Pharmacologyonline 2008;3:336-45
   Google Scholar
• Kajaria D, Tripathi JS, Tiwari SK, Pandey BL. In-vitro evaluation of immunomodulatory effect of polyherbal compound – bharangyadi. J Drug Deliv Ther 2013;3(1):36-9
   Google Scholar
• Hollman PC, de Vries JH, van Leeuwen SD, et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62(6):1276-82
   PubMed Web of Science ®Google Scholar
• Patel J, Patel R, Khambholja K, Patel N. An overview of phytosomes as an advanced herbal drug delivery system. Asian J Pharm Sci 2009;4(6):363-71
   Google Scholar
• Spelman K, Burns J, Nichols D, et al. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006;11(2):128-50
   PubMed Web of Science ®Google Scholar
• Jang SI, Kim DK, Lillehoj HS, et al. Evaluation of Montanide ISA 71 VG adjuvant during profilin vaccination against experimental coccidiosis. PLoS One 2013;8(4):e59786
   PubMed Web of Science ®Google Scholar
• Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. Adv Drug Deliv Rev 2009;61(3):226-32
   PubMed Web of Science ®Google Scholar
• Silva DG, Cooper PD, Petrovsky N. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses. Immunol Cell Biol 2004;82(6):611-16
   PubMed Web of Science ®Google Scholar
• Feinen B, Petrovsky N, Verma A, Merkel TJ. Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant. Clin Vaccine Immunol 2014;21(4):580-6
   PubMed Web of Science ®Google Scholar
• Lebel MÈ, Daudelin JF, Chartrand K, et al. Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from listeria monocytogenes infection. J Immunol 2014;192(3):1071-8
   PubMed Web of Science ®Google Scholar
• Grover A, Troudt J, Foster C, et al. High mobility group box 1 (HMGB1) acts as an adjuvant for tuberculosis subunit vaccines. Immunology 2014;142(1):111-23
   PubMed Web of Science ®Google Scholar
• Chua BY, Olson MR, Bedoui S, et al. The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses. Immunol Cell Biol 2014;92(4):377-83
   PubMed Web of Science ®Google Scholar
• Kindrachuk J, Jenssen H, Elliott M, et al. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 2009;27(34):4662-71
   PubMed Web of Science ®Google Scholar
• Miller MM, Fogle JE, Tompkins MB. Infection with feline immunodeficiency virus directly activates CD4+ CD25+ T regulatory cells. J Virol 2013;87(16):9373-8
   PubMed Web of Science ®Google Scholar
• Brincks EL, Roberts AD, Cookenham T, et al. Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection. J Immunol 2013;190(7):3438-46
   PubMed Web of Science ®Google Scholar
• Luhn K, Simmons CP, Moran E, et al. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 2007;204(5):979-85
   PubMed Web of Science ®Google Scholar
• Bayry J. Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy. Virusdisease 2014;25(1):18-25
   Google Scholar
• Han S, Quach T, Hu L, et al. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies. J Control Release 2014;177C:1-10
   Google Scholar
• Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med 2013;19(12):1597-608
   PubMed Web of Science ®Google Scholar
• Devillea S, Carneaux E, Bertranda F, et al. Adjuvant formulation for companion animals vaccines. Procedia Vaccinol 2011;4:104-12
   Google Scholar